Tag: SELLAS
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2023...
First Patients Dosed in Phase 2a Clinical Trial of SLS009 (formerly GFH009) in Acute Myeloid Leukemia with Topline Data Expected in 4Q 2023Phase...
SELLAS Life Sciences Announces Pricing of $25.0 Million Underwritten Public Offe…...
NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. SLS ("SELLAS" or the "Company"), a late-stage clinical...